As preliminary results, the ratio of apolipoprotein B and apolipoprotein A-1 (apoB/A) ratio were identified as a reliable prognostic factor for predicting the overall survival (OS) for CRC patients, which provided evidence for individualized treatment strategies in the future. The gene discussed is APOB; the disease is colorectal carcinoma.